Rapid transient production in plants by replicating and non-replicating vectors yields high quality functional anti-HIV antibody
- PMID: 21103044
- PMCID: PMC2980466
- DOI: 10.1371/journal.pone.0013976
Rapid transient production in plants by replicating and non-replicating vectors yields high quality functional anti-HIV antibody
Abstract
Background: The capacity of plants and plant cells to produce large amounts of recombinant protein has been well established. Due to advantages in terms of speed and yield, attention has recently turned towards the use of transient expression systems, including viral vectors, to produce proteins of pharmaceutical interest in plants. However, the effects of such high level expression from viral vectors and concomitant effects on host cells may affect the quality of the recombinant product.
Methodology/principal findings: To assess the quality of antibodies transiently expressed to high levels in plants, we have expressed and characterised the human anti-HIV monoclonal antibody, 2G12, using both replicating and non-replicating systems based on deleted versions of Cowpea mosaic virus (CPMV) RNA-2. The highest yield (approximately 100 mg/kg wet weight leaf tissue) of affinity purified 2G12 was obtained when the non-replicating CPMV-HT system was used and the antibody was retained in the endoplasmic reticulum (ER). Glycan analysis by mass-spectrometry showed that the glycosylation pattern was determined exclusively by whether the antibody was retained in the ER and did not depend on whether a replicating or non-replicating system was used. Characterisation of the binding and neutralisation properties of all the purified 2G12 variants from plants showed that these were generally similar to those of the Chinese hamster ovary (CHO) cell-produced 2G12.
Conclusions: Overall, the results demonstrate that replicating and non-replicating CPMV-based vectors are able to direct the production of a recombinant IgG similar in activity to the CHO-produced control. Thus, a complex recombinant protein was produced with no apparent effect on its biochemical properties using either high-level expression or viral replication. The speed with which a recombinant pharmaceutical with excellent biochemical characteristics can be produced transiently in plants makes CPMV-based expression vectors an attractive option for biopharmaceutical development and production.
Conflict of interest statement
Figures
Similar articles
-
Influence of elastin-like peptide fusions on the quantity and quality of a tobacco-derived human immunodeficiency virus-neutralizing antibody.Plant Biotechnol J. 2009 Dec;7(9):899-913. doi: 10.1111/j.1467-7652.2009.00452.x. Epub 2009 Oct 13. Plant Biotechnol J. 2009. PMID: 19843249
-
Fc-glycosylation influences Fcγ receptor binding and cell-mediated anti-HIV activity of monoclonal antibody 2G12.J Immunol. 2010 Dec 1;185(11):6876-82. doi: 10.4049/jimmunol.1002600. Epub 2010 Nov 1. J Immunol. 2010. PMID: 21041724
-
CRISPR/Cas9-mediated knockout of six glycosyltransferase genes in Nicotiana benthamiana for the production of recombinant proteins lacking β-1,2-xylose and core α-1,3-fucose.Plant Biotechnol J. 2019 Feb;17(2):350-361. doi: 10.1111/pbi.12981. Epub 2018 Aug 11. Plant Biotechnol J. 2019. PMID: 29969180 Free PMC article.
-
The pEAQ vector series: the easy and quick way to produce recombinant proteins in plants.Plant Mol Biol. 2013 Sep;83(1-2):51-8. doi: 10.1007/s11103-013-0036-1. Epub 2013 Mar 12. Plant Mol Biol. 2013. PMID: 23479085 Review.
-
Plant virus expression vectors set the stage as production platforms for biopharmaceutical proteins.Virology. 2012 Nov 10;433(1):1-6. doi: 10.1016/j.virol.2012.06.012. Virology. 2012. PMID: 22979981 Review.
Cited by
-
The B cell death function of obinutuzumab-HDEL produced in plant (Nicotiana benthamiana L.) is equivalent to obinutuzumab produced in CHO cells.PLoS One. 2018 Jan 11;13(1):e0191075. doi: 10.1371/journal.pone.0191075. eCollection 2018. PLoS One. 2018. PMID: 29324849 Free PMC article.
-
In plant activation: an inducible, hyperexpression platform for recombinant protein production in plants.Plant Cell. 2013 Jul;25(7):2429-43. doi: 10.1105/tpc.113.113944. Epub 2013 Jul 9. Plant Cell. 2013. PMID: 23839786 Free PMC article.
-
Exploiting plant virus-derived components to achieve in planta expression and for templates for synthetic biology applications.New Phytol. 2013 Oct;200(1):16-26. doi: 10.1111/nph.12204. Epub 2013 Mar 4. New Phytol. 2013. PMID: 23452220 Free PMC article. Review.
-
Engineering of human-type O-glycosylation in Nicotiana benthamiana plants.Bioengineered. 2013 Jul-Aug;4(4):191-6. doi: 10.4161/bioe.22857. Epub 2012 Nov 12. Bioengineered. 2013. PMID: 23147167 Free PMC article.
-
Protection of recombinant mammalian antibodies from development-dependent proteolysis in leaves of Nicotiana benthamiana.PLoS One. 2013 Jul 23;8(7):e70203. doi: 10.1371/journal.pone.0070203. Print 2013. PLoS One. 2013. PMID: 23894618 Free PMC article.
References
-
- Gleba Y, Klimyuk V, Marillonnet S. Viral vectors for the expression of proteins in plants. Current Opinion in Biotechnology. 2007;18:134–141. - PubMed
-
- Komarova TV, Skulachev MV, Zvereva AS, Schwartz AM, Dorokhov YL, et al. New viral vector for efficient production of target proteins in plants. Biochemistry (Moscow) 2006;71:846–850. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources